chronic obsrtuctive pulmonary disease. Other secondary pulmonary hypertension
Conditions
Interventions
Intervention 1: Intervention In the intervention group: with chronic obstructive pulmonary disease hospitalized in Imam Khomeini Hospital in this group, verapamil in the form of inhalation and in the
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with proven chronic obstructive pulmonary disease based on spirometry criteria and patient history Patients with proven chronic obstructive pulmonary disease and hospitalized in Imam Khomeini Hospital
Exclusion criteria
Exclusion criteria: Valvular heart disease more than moderate Pulmonary valve stenosis History of renal failure History of liver cirrhosis History of pulmonary embolism Congenital heart disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary artery systolic pressure reduction. Timepoint: Pulmonary artery systolic pressure was measured by echocardiography at the beginning of the study (before the intervention) and 1 hour after receiving inhaled verapamil. Method of measurement: Echocardiography device Affiniti 50. | — |
Secondary
| Measure | Time frame |
|---|---|
| The increase in oxygen saturation of arterial blood. Timepoint: Arterial blood oxygen saturation is measured before receiving inhaled verapamil (pre-intervention) and 1 hour after the intervention. Method of measurement: Measurement of arterial blood oxygen saturation is done by finger pulse oximeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Kazem Gharloghi
Tehran University of Medical Sciences
Outcome results
None listed